PMC:7361216 / 4423-4595
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T56 | 32-35 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T57 | 104-107 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T58 | 108-116 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T59 | 151-156 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 36-57 | Disease | denotes | monoclonal gammopathy | http://purl.obolibrary.org/obo/MONDO_0004960 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T65 | 149-156 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cells |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 151-156 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cells |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T27 | 0-172 | Sentence | denotes | In patients suffering from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituximab. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 122 | 3-11 | Species | denotes | patients | Tax:9606 |
| 123 | 162-171 | Chemical | denotes | Rituximab | MESH:D000069283 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T50 | 144-148 | Protein | denotes | CD20 | https://www.uniprot.org/uniprot/Q3C2E2|https://www.uniprot.org/uniprot/Q13963|https://www.uniprot.org/uniprot/P19437|https://www.uniprot.org/uniprot/P11836|https://www.uniprot.org/uniprot/P08984|https://www.uniprot.org/uniprot/B4DT24|https://www.uniprot.org/uniprot/A6NMS4 |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T56 | 32-35 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T57 | 104-107 | Body_part | denotes | IgM | http://purl.org/sig/ont/fma/fma62873 |
| T58 | 108-116 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T59 | 151-156 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T15 | 36-57 | Disease | denotes | monoclonal gammopathy | http://purl.obolibrary.org/obo/MONDO_0004960 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T27 | 0-172 | Sentence | denotes | In patients suffering from this IgM monoclonal gammopathy, non‐specific strategies are used to diminish IgM antibody including targeting of all CD20 B cells with Rituximab. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 122 | 3-11 | Species | denotes | patients | Tax:9606 |
| 123 | 162-171 | Chemical | denotes | Rituximab | MESH:D000069283 |